StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)

Close on Nov 17, 2026Market cap $3.99MP/E –Yield –

Sonoma Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Sonoma Pharmaceuticals's total assets was $18.11M at Jun 30, 2026. For fiscal 2026 it was $13.96M, up 1.9% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $25.46M in fiscal 2017.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026$13.96M+1.9%
FY2025Mar 31, 2025$13.69M-7.1%
FY2024Mar 31, 2024$14.74M-9.2%
FY2023Mar 31, 2023$16.23M-13.9%
FY2022Mar 31, 2022$18.85M+25.7%
FY2021Mar 31, 2021$14.99M+2.9%
FY2020Mar 31, 2020$14.56M+0.8%
FY2019Mar 31, 2019$14.45M-24.8%
FY2018Mar 31, 2018$19.21M-24.6%
FY2017Mar 31, 2017$25.46M+84.4%
FY2016Mar 31, 2016$13.80M-8.3%
FY2015Mar 31, 2015$15.05M-27.6%
FY2014Mar 31, 2014$20.79M+65.5%
FY2013Mar 31, 2013$12.57M+60.3%
FY2012Mar 31, 2012$7.84M-9.5%
FY2011Mar 31, 2011$8.66M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$18.11M+24.1%
Q4 FY2026CQ1 2026Mar 31, 2026$13.96M+1.9%
Q3 FY2026CQ4 2025Dec 31, 2025$13.62M-0.3%
Q2 FY2026CQ3 2025Sep 30, 2025$13.86M+1.2%
Q1 FY2026CQ2 2025Jun 30, 2025$14.59M+6.7%
Q4 FY2025CQ1 2025Mar 31, 2025$13.69M-7.1%
Q3 FY2025CQ4 2024Dec 31, 2024$13.67M-6.5%
Q2 FY2025CQ3 2024Sep 30, 2024$13.69M+0.4%
Q1 FY2025CQ2 2024Jun 30, 2024$13.67M-14.0%
Q4 FY2024CQ1 2024Mar 31, 2024$14.74M-9.2%
Q3 FY2024CQ4 2023Dec 31, 2023$14.62M+5.0%
Q2 FY2024CQ3 2023Sep 30, 2023$13.64M-8.9%
Q1 FY2024CQ2 2023Jun 30, 2023$15.89M-7.4%
Q4 FY2023CQ1 2023Mar 31, 2023$16.23M-13.9%
Q3 FY2023CQ4 2022Dec 31, 2022$13.93M-28.0%
Q2 FY2023CQ3 2022Sep 30, 2022$14.96M-24.5%
Q1 FY2023CQ2 2022Jun 30, 2022$17.16M+21.5%
Q4 FY2022CQ1 2022Mar 31, 2022$18.85M+25.7%
Q3 FY2022CQ4 2021Dec 31, 2021$19.35M+6.1%
Q2 FY2022CQ3 2021Sep 30, 2021$19.83M+9.3%
Q1 FY2022CQ2 2021Jun 30, 2021$14.12M-21.9%
Q4 FY2021CQ1 2021Mar 31, 2021$14.99M+2.9%
Q3 FY2021CQ4 2020Dec 31, 2020$18.23M+10.5%
Q2 FY2021CQ3 2020Sep 30, 2020$18.15M+12.4%
Q1 FY2021CQ2 2020Jun 30, 2020$18.08M+6.9%
Q4 FY2020CQ1 2020Mar 31, 2020$14.56M+0.8%
Q3 FY2020CQ4 2019Dec 31, 2019$16.50M-3.2%
Q2 FY2020CQ3 2019Sep 30, 2019$16.15M+12.5%
Q1 FY2020CQ2 2019Jun 30, 2019$16.92M+1.7%
Q4 FY2019CQ1 2019Mar 31, 2019$14.45M-24.8%
Q3 FY2019CQ4 2018Dec 31, 2018$17.05M-7.1%
Q2 FY2019CQ3 2018Sep 30, 2018$14.35M-28.8%
Q1 FY2019CQ2 2018Jun 30, 2018$16.63M-25.8%
Q4 FY2018CQ1 2018Mar 31, 2018$19.21M-24.6%
Q3 FY2018CQ4 2017Dec 31, 2017$18.36M-33.3%
Q2 FY2018CQ3 2017Sep 30, 2017$20.15M+118.1%
Q1 FY2018CQ2 2017Jun 30, 2017$22.42M–
Q4 FY2017CQ1 2017Mar 31, 2017$25.46M–
Q3 FY2017CQ4 2016Dec 31, 2016$27.51M–
Q2 FY2017CQ3 2016Sep 30, 2016$9.24M–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?